Cigarette smoking status has a modifying effect on the association between polymorphisms in KALRN and measures of cardiovascular risk in the diabetes heart study

All manifestations of cardiovascular disease (CVD) are substantially more common in patients with type 2 diabetes mellitus (T2DM) than in non-diabetic individuals. The current study evaluated KALRN , a gene previously linked to CVD, as a contributor to CVD in a sample enriched for T2DM. Specifically...

Full description

Saved in:
Bibliographic Details
Published in:Genes & genomics Vol. 33; no. 5; pp. 483 - 490
Main Authors: Rudock, Megan E., Cox, Amanda. J., Ziegler, Julie T., Lehtinen, Allison B., Connelly, Jessica J., Freedman, Barry I., Carr, J. Jeffrey, Langefeld, Carl D., Hauser, Elizabeth R., Horne, Benjamin D., Bowden, Donald W.
Format: Journal Article
Language:English
Published: Heidelberg The Genetics Society of Korea 01.10.2011
한국유전학회
Subjects:
Animal Genetics and Genomics
Biomedical and Life Sciences
Human Genetics
Life Sciences
Microbial Genetics and Genomics
Plant Genetics and Genomics
Research Article
생물학
Type 2 diabetes
Kalirin
Polymorphisms
Vascular Calcification
ISSN:1976-9571, 2092-9293
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:All manifestations of cardiovascular disease (CVD) are substantially more common in patients with type 2 diabetes mellitus (T2DM) than in non-diabetic individuals. The current study evaluated KALRN , a gene previously linked to CVD, as a contributor to CVD in a sample enriched for T2DM. Specifically, the potential modifying effect of cigarette smoking was examined. A total of 28 SNPs in KALRN were genotyped in 1001 European Americans from 369 Diabetes Heart Study (DHS) families, as well as 762 population-based controls. The association between each SNP and both qualitative and quantitative CVD disease phenotypes was determined using generalized estimating equations and variance component models, respectively. Selected KALRN SNPs were found to be associated with both the qualitative (T2DM, CVD, metabolic syndrome) and quantitative traits (C-reactive protein and abdominal aortic calcified plaque). Interaction analysis and stratification were then used to test whether smoking modulates the genetic effects of KALRN . The strongest evidence of a modifying effect of smoking status was observed for rs9289231 and intima-media thickness (p=9.0x10 −4 ) and abdominal aortic calcified plaque (p=3.0×10 −4 ). Overall, following stratification by smoking status, the evidence of association with quantitative traits was more pronounced in smokers compared to non-smokers. The strongest association for smokers was between rs1720960 and abdominal aortic calcified plaque (p=2.6x10 −5 ), while in non-smokers there was no observed association. KALRN variants are associated with measures of CVD and T2DM in the DHS sample with smoking status observed to have a significant modifying effect on these associations.
Bibliography:G704-000317.2011.33.5.001
ISSN:1976-9571
2092-9293
DOI:10.1007/s13258-011-0069-2